Dr. Shahzad Siddique
Claim this profilePenrose-Saint Francis Healthcare
Expert in Skin Cancer
Expert in Cancer
117 reported clinical trials
183 drugs studied
About Shahzad Siddique
Education:
- Earned a Medical Degree (MD).
Experience:
- Served as Principal Investigator for the clinical trial "Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects."
Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage I
Stage II
2Cancer
Global LeaderStage IV
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Shahzad Siddique is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting1 award Phase 221 criteria
More about Shahzad Siddique
Clinical Trial Related4 years of experience running clinical trials · Led 117 trials as a Principal Investigator · 84 Active Clinical TrialsTreatments Shahzad Siddique has experience with
- Nivolumab
- Carboplatin
- Cisplatin
- Pembrolizumab
- Paclitaxel
- Atezolizumab
Breakdown of trials Shahzad Siddique has run
Skin Cancer
Cancer
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shahzad Siddique specialize in?
Shahzad Siddique focuses on Skin Cancer and Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage I.
Is Shahzad Siddique currently recruiting for clinical trials?
Yes, Shahzad Siddique is currently recruiting for 82 clinical trials in Colorado Springs Colorado. If you're interested in participating, you should apply.
Are there any treatments that Shahzad Siddique has studied deeply?
Yes, Shahzad Siddique has studied treatments such as Nivolumab, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with Shahzad Siddique?
Apply for one of the trials that Shahzad Siddique is conducting.
What is the office address of Shahzad Siddique?
The office of Shahzad Siddique is located at: Penrose-Saint Francis Healthcare, Colorado Springs, Colorado 80907 United States. This is the address for their practice at the Penrose-Saint Francis Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.